ArticleExperimental and therapeutic medicine2024

Partial response of hepatocellular carcinoma to lenalidomide following progression in response to lenvatinib: A case report.

Xu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.